Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease.

Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ.

Front Neurol. 2019 Apr 24;10:391. doi: 10.3389/fneur.2019.00391. eCollection 2019.

2.

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2019 Mar;34(3):430-435. doi: 10.1002/mds.27617. Epub 2019 Jan 17.

PMID:
30653248
3.

Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.

Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D; IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2018 Nov;33(11):1750-1759. doi: 10.1002/mds.110. Epub 2018 Sep 14.

PMID:
30216541
4.

Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis.

Castellazzi G, Debernard L, Melzer TR, Dalrymple-Alford JC, D'Angelo E, Miller DH, Gandini Wheeler-Kingshott CAM, Mason DF.

Front Neurol. 2018 Aug 20;9:690. doi: 10.3389/fneur.2018.00690. eCollection 2018.

5.

Environmental enrichment increases prefrontal EEG power and synchrony with the hippocampus in rats with anterior thalamus lesions.

Ulrich K, Spriggs MJ, Abraham WC, Dalrymple-Alford JC, McNaughton N.

Hippocampus. 2019 Feb;29(2):128-140. doi: 10.1002/hipo.23022. Epub 2018 Nov 22.

PMID:
30153381
6.

Environmental Enrichment Elicits a Transient Rise of Bioactive C-Type Natriuretic Peptide in Young but Not Aged Rats.

Rapley SA, Prickett TCR, Dalrymple-Alford JC, Espiner EA.

Front Behav Neurosci. 2018 Jul 19;12:142. doi: 10.3389/fnbeh.2018.00142. eCollection 2018.

7.

Parkinson's disease across ethnicities: A nationwide study in New Zealand.

Pitcher TL, Myall DJ, Pearson JF, Lacey CJ, Dalrymple-Alford JC, Anderson TJ, MacAskill MR.

Mov Disord. 2018 Sep;33(9):1440-1448. doi: 10.1002/mds.27389. Epub 2018 Jul 23.

PMID:
30035822
8.

Optogenetic stimulation: Understanding memory and treating deficits.

Barnett SC, Perry BAL, Dalrymple-Alford JC, Parr-Brownlie LC.

Hippocampus. 2018 Jul;28(7):457-470. doi: 10.1002/hipo.22960. Review.

PMID:
29742814
9.

Lesions of the mammillothalamic tract and anterior thalamic nuclei: Response to Vann and Nelson (2018).

Dalrymple-Alford JC, Perry BAL.

Hippocampus. 2018 Oct;28(10):694-697. doi: 10.1002/hipo.22963. Epub 2018 Jul 3. No abstract available.

PMID:
29742808
10.

Response to "Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms".

Horne KL, Myall DJ, MacAskill MR, Anderson TJ, Dalrymple-Alford JC.

Int Psychogeriatr. 2018 Sep;30(9):1415. doi: 10.1017/S1041610218000091. Epub 2018 Apr 2.

PMID:
29606167
11.

Anterior thalamic nuclei lesions have a greater impact than mammillothalamic tract lesions on the extended hippocampal system.

Perry BAL, Mercer SA, Barnett SC, Lee J, Dalrymple-Alford JC.

Hippocampus. 2018 Feb;28(2):121-135. doi: 10.1002/hipo.22815. Epub 2017 Nov 29.

PMID:
29150979
12.

Parkinson's in the oldest old: Impact on estimates of future disease burden.

Myall DJ, Pitcher TL, Pearson JF, Dalrymple-Alford JC, Anderson TJ, MacAskill MR.

Parkinsonism Relat Disord. 2017 Sep;42:78-84. doi: 10.1016/j.parkreldis.2017.06.018. Epub 2017 Jun 27.

PMID:
28693940
13.

Caregiver burden is increased in Parkinson's disease with mild cognitive impairment (PD-MCI).

Jones AJ, Kuijer RG, Livingston L, Myall D, Horne K, MacAskill M, Pitcher T, Barrett PT, Anderson TJ, Dalrymple-Alford JC.

Transl Neurodegener. 2017 Jun 19;6:17. doi: 10.1186/s40035-017-0085-5. eCollection 2017.

14.

Mild cognitive impairment as a risk factor for Parkinson's disease dementia.

Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2017 Jul;32(7):1056-1065. doi: 10.1002/mds.27002. Epub 2017 Jun 12.

15.

Attention lapses and behavioural microsleeps during tracking, psychomotor vigilance, and dual tasks.

Buckley RJ, Helton WS, Innes CRH, Dalrymple-Alford JC, Jones RD.

Conscious Cogn. 2016 Oct;45:174-183. doi: 10.1016/j.concog.2016.09.002. Epub 2016 Sep 14.

PMID:
27619820
16.

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.

Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF; SNCA Cognition Study Group, Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ.

Ann Neurol. 2016 Jun;79(6):991-9. doi: 10.1002/ana.24664. Epub 2016 May 5.

17.

Acute tryptophan depletion and Lewy body dementias.

Mace JL, Porter RJ, Dalrymple-Alford JC, Collins C, Anderson TJ.

Int Psychogeriatr. 2016 Sep;28(9):1487-91. doi: 10.1017/S1041610216000284. Epub 2016 Mar 18.

PMID:
26987723
18.

Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal study.

Wood KL, Myall DJ, Livingston L, Melzer TR, Pitcher TL, MacAskill MR, Geurtsen GJ, Anderson TJ, Dalrymple-Alford JC.

NPJ Parkinsons Dis. 2016 Jan 14;2:15027. doi: 10.1038/npjparkd.2015.27. eCollection 2016.

19.

Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease.

Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Watts R, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.

PLoS One. 2015 Dec 29;10(12):e0143923. doi: 10.1371/journal.pone.0143923. eCollection 2015.

20.

Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.

Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.

Parkinsonism Relat Disord. 2016 Jan;22:54-61. doi: 10.1016/j.parkreldis.2015.11.008. Epub 2015 Nov 12.

PMID:
26627939
21.

Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.

Debernard L, Melzer TR, Alla S, Eagle J, Van Stockum S, Graham C, Osborne JR, Dalrymple-Alford JC, Miller DH, Mason DF.

Psychiatry Res. 2015 Dec 30;234(3):352-61. doi: 10.1016/j.pscychresns.2015.10.004. Epub 2015 Oct 22.

PMID:
26602610
22.

Construction of joint confidence regions for the optimal true class fractions of Receiver Operating Characteristic (ROC) surfaces and manifolds.

Bantis LE, Nakas CT, Reiser B, Myall D, Dalrymple-Alford JC.

Stat Methods Med Res. 2017 Jun;26(3):1429-1442. doi: 10.1177/0962280215581694. Epub 2015 Apr 24.

PMID:
25911331
23.

Impaired spatial working memory after anterior thalamic lesions: recovery with cerebrolysin and enrichment.

Loukavenko EA, Wolff M, Poirier GL, Dalrymple-Alford JC.

Brain Struct Funct. 2016 May;221(4):1955-70. doi: 10.1007/s00429-015-1015-x. Epub 2015 Mar 1.

PMID:
25725627
24.

Prediction of driving ability: Are we building valid models?

Hoggarth PA, Innes CR, Dalrymple-Alford JC, Jones RD.

Accid Anal Prev. 2015 Apr;77:29-34. doi: 10.1016/j.aap.2015.01.013. Epub 2015 Feb 6.

PMID:
25667204
25.

Anterior thalamic nuclei lesions and recovery of function: Relevance to cognitive thalamus.

Dalrymple-Alford JC, Harland B, Loukavenko EA, Perry B, Mercer S, Collings DA, Ulrich K, Abraham WC, McNaughton N, Wolff M.

Neurosci Biobehav Rev. 2015 Jul;54:145-60. doi: 10.1016/j.neubiorev.2014.12.007. Epub 2015 Jan 29. Review.

PMID:
25637779
26.

Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington's disease: a 12-month longitudinal study.

Toh EA, MacAskill MR, Dalrymple-Alford JC, Myall DJ, Livingston L, Macleod SA, Anderson TJ.

Transl Neurodegener. 2014 Jul 12;3:15. doi: 10.1186/2047-9158-3-15. eCollection 2014.

27.

Anterior thalamic lesions reduce spine density in both hippocampal CA1 and retrosplenial cortex, but enrichment rescues CA1 spines only.

Harland BC, Collings DA, McNaughton N, Abraham WC, Dalrymple-Alford JC.

Hippocampus. 2014 Oct;24(10):1232-47. doi: 10.1002/hipo.22309. Epub 2014 Jun 13.

PMID:
24862603
28.

Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.

Le Heron CJ, Wright SL, Melzer TR, Myall DJ, MacAskill MR, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, Anderson TJ.

J Cereb Blood Flow Metab. 2014 Jun;34(6):964-70. doi: 10.1038/jcbfm.2014.40. Epub 2014 Mar 12.

29.
30.

Effects of thalamic lesions on repeated relearning of a spatial working memory task.

Ulrich K, Aitken PN, Abraham WC, Dalrymple-Alford JC, McNaughton N.

Behav Brain Res. 2014 Mar 15;261:56-9. doi: 10.1016/j.bbr.2013.12.002. Epub 2013 Dec 12.

PMID:
24333378
31.

C-type natriuretic peptide in Parkinson's disease: reduced secretion and response to deprenyl.

Espiner EA, Dalrymple-Alford JC, Prickett TC, Alamri Y, Anderson TJ.

J Neural Transm (Vienna). 2014 Apr;121(4):371-8. doi: 10.1007/s00702-013-1123-9. Epub 2013 Dec 5.

PMID:
24306276
32.

Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.

Debernard L, Melzer TR, Van Stockum S, Graham C, Wheeler-Kingshott CA, Dalrymple-Alford JC, Miller DH, Mason DF.

J Neurol Neurosurg Psychiatry. 2014 May;85(5):544-51. doi: 10.1136/jnnp-2013-305612. Epub 2013 Sep 13.

PMID:
24039024
33.

The reuniens and rhomboid nuclei: neuroanatomy, electrophysiological characteristics and behavioral implications.

Cassel JC, Pereira de Vasconcelos A, Loureiro M, Cholvin T, Dalrymple-Alford JC, Vertes RP.

Prog Neurobiol. 2013 Dec;111:34-52. doi: 10.1016/j.pneurobio.2013.08.006. Epub 2013 Sep 8. Review.

34.

White matter microstructure deteriorates across cognitive stages in Parkinson disease.

Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.

Neurology. 2013 May 14;80(20):1841-9. doi: 10.1212/WNL.0b013e3182929f62. Epub 2013 Apr 17.

PMID:
23596076
35.

Reduced striatal volumes in Parkinson's disease: a magnetic resonance imaging study.

Pitcher TL, Melzer TR, Macaskill MR, Graham CF, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, Anderson TJ.

Transl Neurodegener. 2012 Aug 21;1(1):17. doi: 10.1186/2047-9158-1-17.

36.

The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease.

Macaskill MR, Graham CF, Pitcher TL, Myall DJ, Livingston L, van Stockum S, Dalrymple-Alford JC, Anderson TJ.

Neuropsychologia. 2012 Dec;50(14):3338-47. doi: 10.1016/j.neuropsychologia.2012.09.025. Epub 2012 Sep 19.

PMID:
23000134
37.

Generalization of Youden index for multiple-class classification problems applied to the assessment of externally validated cognition in Parkinson disease screening.

Nakas CT, Dalrymple-Alford JC, Anderson TJ, Alonzo TA.

Stat Med. 2013 Mar 15;32(6):995-1003. doi: 10.1002/sim.5592. Epub 2012 Sep 4.

PMID:
22949169
38.

Grey matter atrophy in cognitively impaired Parkinson's disease.

Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):188-94. doi: 10.1136/jnnp-2011-300828. Epub 2011 Sep 2.

PMID:
21890574
39.

Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Melzer TR, Watts R, MacAskill MR, Pearson JF, Rüeger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A, Alsop DC, Dalrymple-Alford JC, Anderson TJ.

Brain. 2011 Mar;134(Pt 3):845-55. doi: 10.1093/brain/awq377. Epub 2011 Feb 9.

40.

Characterizing mild cognitive impairment in Parkinson's disease.

Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, Watts R, Anderson TJ.

Mov Disord. 2011 Mar;26(4):629-36. doi: 10.1002/mds.23592. Epub 2011 Feb 1.

PMID:
21287603
41.

The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly.

Mace JL, Porter RJ, Dalrymple-Alford JC, Wesnes KA, Anderson TJ.

J Psychopharmacol. 2011 Oct;25(10):1337-43. doi: 10.1177/0269881110389094. Epub 2011 Jan 24.

PMID:
21262857
42.

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ.

Neurology. 2010 Nov 9;75(19):1717-25. doi: 10.1212/WNL.0b013e3181fc29c9.

PMID:
21060094
43.

Comparison of a linear and a non-linear model for using sensory-motor, cognitive, personality, and demographic data to predict driving ability in healthy older adults.

Hoggarth PA, Innes CR, Dalrymple-Alford JC, Severinsen JE, Jones RD.

Accid Anal Prev. 2010 Nov;42(6):1759-68. doi: 10.1016/j.aap.2010.04.017. Epub 2010 May 26.

PMID:
20728627
44.

Different lip asymmetry in adults who stutter: electromyographic evidence during speech and non-speech.

Choo AL, Robb MP, Dalrymple-Alford JC, Huckabee ML, O'Beirne GA.

Folia Phoniatr Logop. 2010;62(3):143-7. doi: 10.1159/000287213. Epub 2010 Apr 29.

45.

Assessing cognitive impairment in Parkinson's disease: a comparison of two tower tasks.

McKinlay A, Grace RC, Kaller CP, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D.

Appl Neuropsychol. 2009 Jul;16(3):177-85. doi: 10.1080/09084280903098661.

PMID:
20183170
46.

Characteristics of executive function impairment in Parkinson's disease patients without dementia.

McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D.

J Int Neuropsychol Soc. 2010 Mar;16(2):268-77. doi: 10.1017/S1355617709991299. Epub 2009 Dec 11.

PMID:
20003582
47.

Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.

McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D.

Dement Geriatr Cogn Disord. 2009;28(2):121-9. doi: 10.1159/000235247. Epub 2009 Aug 18.

48.

The effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly.

Mace JL, Porter RJ, Dalrymple-Alford JC, Anderson TJ.

J Psychopharmacol. 2010 Apr;24(4):615-9. doi: 10.1177/0269881109105572. Epub 2009 Jul 22.

PMID:
19625388
49.

Virtual reality rehabilitation of spatial abilities after brain damage.

Koenig ST, Crucian GP, Dalrymple-Alford JC, Dünser A.

Stud Health Technol Inform. 2009;144:105-7.

PMID:
19592742
50.

Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease.

Mace JL, Porter RJ, Dalrymple-Alford JC, Wesnes KA, Anderson TJ.

J Psychopharmacol. 2010 Oct;24(10):1465-72. doi: 10.1177/0269881109105721. Epub 2009 May 21.

PMID:
19460872

Supplemental Content

Loading ...
Support Center